All ABUS Content

Analysis

Arbutus Biopharma 2025 Financial Review

 Company Overview Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company focused on infectious diseases.  Key Financial Figures For the year...

March 24, 20261 min read

Arbutus Biopharma Corp (ABUS) Q2 2022 Earnings Call

Arbutus Biopharma Corp (NASDAQ: ABUS) Q2 2022 Earnings Conference

August 1, 20221 min read

Arbutus Biopharma Corp (ABUS) Q1 2022 earnings call

Arbutus Biopharma Corp (NASDAQ: ABUS) Q1 2022 Earnings Conference

May 2, 20221 min read

Arbutus Biopharma Corp (ABUS) Q4 2021 Earnings Conference Call

Arbutus Biopharma Corp (NASDAQ: ABUS) Q4 2021 Earnings Conference

February 23, 20221 min read

Arbutus Biopharma Corp (ABUS) Arbutus to Report Third Quarter 2021 Financial Results and Provide Corporate Update

Arbutus Biopharma Corp (NASDAQ: ABUS) Q3 2021 Earnings Conference

November 8, 20211 min read

Arbutus Biopharma Corp (ABUS) 2Q21 Earnings Call

Arbutus Biopharma Corp (NASDAQ: ABUS) Q2 2021 Earnings Conference

August 9, 20211 min read

Arbutus Biopharma Corp (ABUS) Arbutus Reports Fourth Quarter and Year End 2020 Financial Results and Provides Corporate Update

Arbutus Biopharma Corp (NASDAQ: ABUS) Q4 2020 Earnings Conference

February 26, 20211 min read

Market News

Arbutus Biopharma (ABUS): FY19 Earnings Snapshot

— Arbutus Biopharma Corporation (NASDAQ:ABUS) reported a net loss of $164.9 million or $2.89 per share for fiscal 2019, compared to a loss of $67.2…

March 5, 20201 min read